BTP
|
57227-09-5 |
In-house |
Tiropramide Intermediate |
Commercialized |
RV-142
|
84611-22-3 |
In-house |
Erdosteine Intermediate |
Commercialized |
N-Lauroyl-L-lysine
|
52315-75-0 |
In-house |
Cosmetic Ingredient |
Commercialized |
PDRN (polydeoxyribonucleotide)
|
100403-24-5 |
50 ~ 1,500 kDa |
Repairing, anti-inflamation, anti-aging |
Commercialized.
DMF be finished by Mid of 2026 |
PN (polynucleotide)
|
100403-24-5 |
100 ~ 2,000 kDa |
Repairing, anti-inflamation, anti-aging |
Commercialized.
DMF be finished by Mid of 2026 |
PDLLA (Poly(DL-lactic acid))
|
26680-10-4, 51056-13-9 |
0.16~2.7 dl/g |
Microsphere used for medical beauty filler |
Commercialized |